CordenPharma announced today that it progressed with its more than €1 billion expansion plan for peptide development and manufacturing. As part of its strategy, the company finalized plans to establish a new, state-of-the-art peptide manufacturing facility in Switzerland. located at Getec Park in Muttenz, the plant sits near Basel, a major European biotech and pharma…